39533780|t|Ambroxol Improves Amyloidogenic, NF-kappaB, and Nrf2 Pathways in a Scopolamine-Induced Cognitive Impairment Rat Model of Alzheimer's Disease.
39533780|a|Ambroxol (ABX) is used to manage excessive production of mucus in the respiratory system. The present study sought to assess the neuroprotective potential of ambroxol by influencing the amyloidogenic, nuclear factor kappa-light-chain-enhancer of activated B cells (NF-kappaB), and nuclear factor erythroid 2-related factor 2 (Nrf2) pathways in a rat model of Alzheimer's disease (AD) induced by scopolamine. The AD pathology was induced by chronic administration of scopolamine. The rats were given scopolamine at a dose of 2 mg/kg via intraperitoneal injection daily for 14 days, followed by treatment (ABX 121.5, 135, and 180 mg/kg orally and 5 mg/kg orally of donepezil) for the next 28 days while continuing to receive daily scopolamine injection. The behavior of the rats was evaluated using Modified Y-Maze and Novel object recognition tasks. Analyses were carried out on AD pathological markers [Amyloid beta peptide 1-40, Amyloid beta peptide 1-42, acetylcholinesterase, beta-secretase 1 (BACE1), total tau, and p-tau], inflammatory markers [NF-kappaB, tumor necrosis factor alpha (TNF-alpha), interleukin 6 (IL-6), and interferon gamma], antioxidant markers (Nrf2 and heme Oxygenase 1 (HO-1)], along with synaptophysin and glial fibrillary acidic protein (GFAP) immunohistochemistry and histopathological assessment of the hippocampus. Our findings indicated that ABX reduced impairment in behavior. Levels of Acetylcholinesterase, BACE1, amyloid beta 1-40, amyloid beta 1-42, total tau, p-tau, NF-kappaB, IFN-gamma, IL-6, and TNF-alpha decreased significantly. There was a significant increase in the levels of HO-1 and Nrf2. It stopped the neuronal degeneration, raised synaptophysin immunoreactivity, and lowered GFAP immunoreactivity. The current research indicates that ambroxol may possess senomorphic properties by impacting the transcription factors NF-kappaB and senescence-associated secretory phenotype (SASP). Consequently, it could provide neuroprotection through alterations in the Nrf2 and NF-kappaB signaling pathways in AD.
39533780	0	8	Ambroxol	Chemical	MESH:D000551
39533780	48	52	Nrf2	Gene	83619
39533780	67	78	Scopolamine	Chemical	MESH:D012601
39533780	87	107	Cognitive Impairment	Disease	MESH:D003072
39533780	108	111	Rat	Species	10116
39533780	121	140	Alzheimer's Disease	Disease	MESH:D000544
39533780	142	150	Ambroxol	Chemical	MESH:D000551
39533780	152	155	ABX	Chemical	MESH:D000551
39533780	300	308	ambroxol	Chemical	MESH:D000551
39533780	423	466	nuclear factor erythroid 2-related factor 2	Gene	83619
39533780	468	472	Nrf2	Gene	83619
39533780	488	491	rat	Species	10116
39533780	501	520	Alzheimer's disease	Disease	MESH:D000544
39533780	522	524	AD	Disease	MESH:D000544
39533780	537	548	scopolamine	Chemical	MESH:D012601
39533780	554	556	AD	Disease	MESH:D000544
39533780	608	619	scopolamine	Chemical	MESH:D012601
39533780	625	629	rats	Species	10116
39533780	641	652	scopolamine	Chemical	MESH:D012601
39533780	746	755	ABX 121.5	Chemical	-
39533780	805	814	donepezil	Chemical	MESH:D000077265
39533780	871	882	scopolamine	Chemical	MESH:D012601
39533780	914	918	rats	Species	10116
39533780	1020	1022	AD	Disease	MESH:D000544
39533780	1099	1119	acetylcholinesterase	Gene	83817
39533780	1121	1137	beta-secretase 1	Gene	29392
39533780	1139	1144	BACE1	Gene	29392
39533780	1170	1182	inflammatory	Disease	MESH:D007249
39533780	1203	1230	tumor necrosis factor alpha	Gene	24835
39533780	1232	1241	TNF-alpha	Gene	24835
39533780	1244	1257	interleukin 6	Gene	24498
39533780	1259	1263	IL-6	Gene	24498
39533780	1270	1286	interferon gamma	Gene	25712
39533780	1310	1314	Nrf2	Gene	83619
39533780	1319	1335	heme Oxygenase 1	Gene	24451
39533780	1337	1341	HO-1	Gene	24451
39533780	1356	1369	synaptophysin	Gene	24804
39533780	1374	1405	glial fibrillary acidic protein	Gene	24387
39533780	1407	1411	GFAP	Gene	24387
39533780	1515	1518	ABX	Chemical	MESH:D000551
39533780	1561	1581	Acetylcholinesterase	Gene	83817
39533780	1583	1588	BACE1	Gene	29392
39533780	1657	1666	IFN-gamma	Gene	25712
39533780	1668	1672	IL-6	Gene	24498
39533780	1678	1687	TNF-alpha	Gene	24835
39533780	1763	1767	HO-1	Gene	24451
39533780	1772	1776	Nrf2	Gene	83619
39533780	1793	1814	neuronal degeneration	Disease	MESH:D009410
39533780	1823	1836	synaptophysin	Gene	24804
39533780	1867	1871	GFAP	Gene	24387
39533780	1926	1934	ambroxol	Chemical	MESH:D000551
39533780	2147	2151	Nrf2	Gene	83619
39533780	2188	2190	AD	Disease	MESH:D000544
39533780	Negative_Correlation	MESH:D000551	MESH:D000544
39533780	Association	MESH:D007249	24498
39533780	Association	MESH:D007249	25712
39533780	Negative_Correlation	MESH:D000551	83817
39533780	Positive_Correlation	MESH:D012601	MESH:D003072
39533780	Negative_Correlation	MESH:D000551	24835
39533780	Positive_Correlation	MESH:D000551	24451
39533780	Association	MESH:D007249	24835
39533780	Negative_Correlation	MESH:D000551	24498
39533780	Negative_Correlation	MESH:D000551	24387
39533780	Association	MESH:D000544	29392
39533780	Negative_Correlation	MESH:D000551	29392
39533780	Positive_Correlation	MESH:D012601	MESH:D000544
39533780	Negative_Correlation	MESH:D000551	25712
39533780	Association	MESH:D000551	83619
39533780	Negative_Correlation	MESH:D000551	MESH:D009410

